Peregrine Pharmaceuticals Articles
GlobalData Expert Insight: Fall from grace of Peregrine Pharma
17 October 2012
Peregrine Pharma plummets after revealing "discrepancies" in one bavituximab trial
25 September 2012
Showing 1-4 of 4 articles
- 1
- Boehringer Ingelheim gets FDA warning letter on cGMP failures
- AstraZeneca's naloxegol meets endpoints; EMA validates Gilead's sofosbuvir MAA
- US FDA advisory panel backs approval of Merck & Co's suvorexant, but only at lower doses
- Italy's pharma market slump set to continue, warns GlobalData
- Is failure to adopt business process management putting the pharma industry at risk?
